Log In
BCIQ
Print this Print this
 

2141795

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionProtein kinase B (Akt) inhibitor
Molecular Target Protein kinase B (AKT) (AKT1) (PKB) (PKBA)
Mechanism of ActionAkt inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today